Four researchers from Nijmegen – three from Radboudumc and one from Radboud University – are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20% in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.
Three researchers at the Radboudumc will receive a Vidi grant: Dr Ir Sita Vermeulen, Dr Vivian Weerdesteyn and Dr Christian Gilissen. In addition, one researcher from the Radboud University has also been awarded a Vidi grant: Dr Hanneke den Ouden. Information about the scientists and their research is given below.
Researchers at the Radboudumc
Matching therapy and bladder cancer patient
Dr.ir. Sita Vermeulen Radboudumc – Health Evidence
A good therapy choice in non-muscle invasive bladder cancer requires a test that can predict who will and who will not respond to immunotherapy. The researchers measure changes in the genes of the patient and the bladder tumor to facilitate the development of such a test.
Roads to Recovery
Dr. Vivian Weerdesteyn, Radboudumc – Kinesiology / Rehabilitation medicine
It is yet unknown how various pathways in the brain interact in recovering balance and gait abilities after stroke. The researchers aim to provide insight into this matter. In addition, they will study whether a new training program may enhance balance and gait control, and thereby functioning in daily life.
Integrating Metabolomics and Genomics for understanding human Disease
Dr. Christian Gilissen, Radboudumc – Human Genetics
The identification of disease-causing errors in the DNA is difficult and provides us with limited insights into the workings of the disease. Through bioinformatics methods and data integration of metabolite and DNA data I will improve the identification of genetic causes of disease and find novel leads for therapies.
Researcher at the Radboud University
Getting things done: finding the balance between deciding fast, and deciding well
Dr. Hanneke den Ouden, Radboud University - Donders Institute for Brain, Cognition and Behaviour
"Don't rush decisions!" Good advice, but too much deliberation can lead to missed opportunities. Hanneke Den Ouden will investigate how our brains help us switch between impulsive and thoughtful decision-making strategies. Furthermore, she will research how getting stuck in one particular strategy may be related to negative consequences such as addiction and burn-out.
Read the press release by NWO here
Related news items
Step-up approach vs open necrosectomy for necrotizing pancreatitis18 April 2019
Another publication of the successful Dutch collaborative group on pancreatitis research with substantial contribution from Radboudumc researchers, Harry van Goor and Kees van Laarhoven.read more
Prophylactic antibiotics reduce hospitalisations and cost in head and neck cancer patients18 April 2019
In European journal of cancer Janneke Ham and colleagues showed that prophylactic antibiotics in locally advanced head and neck cancer patients treated with chemoradiotherapy did not reduce the incidence of (aspiration) pneumonias, but did reduce hospitalisations and tended to be cost-effective.read more
Nontuberculous mycobacteria and fungal co-infections Bonnie and Clyde?18 April 2019
In The European respiratory journal Jakko van Ingen and Sanne Zweijpfenning showed that 40% of patients diagnosed with nontuberculous mycobacterial pulmonary disease also meet diagnostic criteria for chronic pulmonary aspergillosis.read more
ESCMID award for groundbreaking studies on NTM disease18 April 2019
Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.read more
EU funded project BIOMAP led by Ellen van den Bogaard12 April 2019
Ellen van den Bogaard, theme Inflammatory diseases, leads the research on the experimental validation and functional analysis of identified biomarkers by using advanced organotypic skin models and receives a grant of €258,000.read more